Literature DB >> 30419426

Well-differentiated papillary mesothelioma: A 17-year single institution experience with a series of 75 cases.

Meng Sun1, Lu Zhao1, I Weng Lao1, Lin Yu1, Jian Wang2.   

Abstract

We present our experience with 75 cases of well-differentiated papillary mesothelioma (WDPM) that were diagnosed at our institution between 2000 and 2017. The patients included 58 females and 17 males with age ranging from 18 to 69 years (mean, 42 years). Clinically, the vast majority of WDPMs were incidental findings during laparotomy or laparoscopic surgery for a variety of benign or malignant disease. The lesion manifested as either a small solitary nodule or multiple miliary nodules on the peritoneum or serosal surfaces of internal organs. Histologically, 67 cases were consistent with a classical WDPM, of which 6 cases contained microinvasive foci and 1 case had malignant transformation. Eight cases were hybrid tumors with variable combined component of adenomatoid tumor (n = 4), multicystic mesothelioma (n = 2), and both (n = 2). By immunohistochemistry, besides calretinin, D2-40, CK5/6 and WT1, 94% (29/31) of cases also showed immunostaining for PAX8. In comparison, PAX8 staining was only present in 12% (6/50) of epithelioid malignant mesothelioma selected as control cases. Follow-up information available in 46 cases revealed no signs of tumor progression or local recurrence except for the case that showed transformation to a fully malignant mesothelioma after a period of 15 years. Our comprehensive study further expanded the clinical and histopathological spectrum of WDPM. Compared with epithelioid malignant mesothelioma, PAX8 staining is highly sensitive and specific for WDPM (P < 0.001).
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  PAX8; Well-differentiated papillary mesothelioma; adenomatoid tumor; multicystic mesothelioma

Mesh:

Substances:

Year:  2018        PMID: 30419426     DOI: 10.1016/j.anndiagpath.2018.10.012

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  4 in total

Review 1.  Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.

Authors:  Alberto M Marchevsky; Andras Khoor; Ann E Walts; Andrew G Nicholson; Yu Zhi Zhang; Victor Roggli; John Carney; Anja C Roden; Henry D Tazelaar; Brandon T Larsen; Nolwenn LeStang; Lucian R Chirieac; Sonja Klebe; Ming-Sound Tsao; Marc De Perrot; Andrew Pierre; David M Hwang; Yin P Hung; Mari Mino-Kenudson; William Travis; Jennifer Sauter; Mary Beth Beasley; Françoise Galateau-Sallé
Journal:  Mod Pathol       Date:  2019-09-04       Impact factor: 7.842

2.  Rethought histologic classification of pleural mesothelioma to better treat: go forward from looking back.

Authors:  Philippe Astoul
Journal:  Transl Lung Cancer Res       Date:  2020-08

3.  Peritoneal mesothelioma in Sweden: A population-based study.

Authors:  Peter H Cashin; Gabriella Jansson Palmer; Dan Asplund; Wilhelm Graf; Ingvar Syk
Journal:  Cancer Med       Date:  2019-09-04       Impact factor: 4.452

4.  A case of slowly progressive malignant pericardial mesothelioma suggesting the involvement of BAP1 loss.

Authors:  Naoto Fukasawa; Yoko Agemi; Aya Shiba; Masaharu Aga; Yusuke Hamakawa; Kazuhito Miyazaki; Yuri Taniguchi; Yuki Misumi; Tsuneo Shimokawa; Kyoko Ono; Hiroyuki Hayashi; Hiroaki Okamoto
Journal:  Respirol Case Rep       Date:  2022-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.